Heart Patients' stomach ulcer prevention study pulled before starting
NCT ID NCT00713947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to see if treating a common stomach bacteria (H. pylori) along with using a stomach acid drug could prevent ulcers caused by low-dose aspirin. It planned to enroll adults with heart or artery disease who needed long-term aspirin therapy. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hotel Dieu Hospital
Paris, 75181, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a fecal transplant beat a stubborn stomach bug?
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes
- Simpler h. pylori treatment could reduce antibiotic use
- AI to predict cancer risk from gut bacteria and scans
- Stool test could replace endoscopy for h. pylori treatment decisions
- New hope against stomach bug in Antibiotic-Resistant region